Dr. Gerber's research focuses on antimicrobial stewardship in both hospital and ambulatory settings, and is funded by NIH, PCORI, AHRQ, and CDC. Specifically, his research focuses on the epidemiology and outcomes of antibiotic use in children with the goal of improving clinical outcomes while limiting the emergence of antimicrobial resistance.

In general, Dr. Gerber’s approach has been to benchmark antimicrobial use across clinical settings to identify high-impact targets for improvement, followed by comparative effectiveness studies for clinical scenarios where practice variability exists in the absence of evidence; interventions to implement and disseminate evidence-based practice where prescribing guidelines do exist; and qualitative assessments of the clinician, practice, or institution-level factors that might drive antimicrobial prescribing.

BA, University of Notre Dame (Psychology), 1994

MD, Temple University School of Medicine, 2003

PhD, Temple University School of Medicine (Microbiology and Immunology), 2003

MS, University of Pennsylvania (Epidemiology), 2010

Associate Chief Clinical Research Officer, CHOP Research Institute

Attending Physician

Distinguished Chair in the Department of Pediatrics

Associate Professor of Pediatrics and Epidemiology

American Academy of Pediatrics, 2003-

Pediatric Infectious Diseases Society, 2006-

Infectious Diseases Society of America, 2006-

Society for Healthcare Epidemiology of America, 2010-

IDWeek Program Committee Choice Award, Infectious Diseases Society of America, 2012

Excellence in Teaching Epidemiology Award, Penn Center for Clinical Epidemiology and Biostatistics, 2016

Marjorie A. Bowman New Investigator Research Award, Perelman School of Medicine at the University of Pennsylvania, 2016

Caroline B. Hall Clinically Innovative Research Award, Pediatric Infectious Diseases Society, 2016

Clinical Futures Profile